ADTX
ADTX
NASDAQ · Biotechnology

Aditxt Inc

$0.04
+0.02 (+117.19%)
As of Jun 23, 10:24 PM ET ·
Financial Highlights (FY 2026)
Revenue
11.18B
Net Income
-2,873,510,358,333
Gross Margin
-368.3%
Profit Margin
-25,708.3%
Rev Growth
+6.8%
D/E Ratio
0.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -368.3% -368.3% 36.5% 36.5%
Operating Margin -20,951.1% -18,856.0% -8.5% -8.3%
Profit Margin -25,708.3% -24,422.8% -10.9% -10.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.18B 10.47B 180.5K 146.0K
Gross Profit -41,166,305,990 -38,545,230,327 65.8K 53.3K
Operating Income -2,341,783,822,340 -1,973,413,333,432 -15,427 -12,144
Net Income -2,873,510,358,333 -2,421,497,492,977 -19,611 -15,138
Gross Margin -368.3% -368.3% 36.5% 36.5%
Operating Margin -20,951.1% -18,856.0% -8.5% -8.3%
Profit Margin -25,708.3% -24,422.8% -10.9% -10.4%
Rev Growth +6.8% +6.8% +10.1% +10.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 77.5K 77.5K 133.1K 136.4K
Total Equity 118.5K 118.5K 143.0K 117.9K
D/E Ratio 0.65 0.65 0.93 1.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,290,571,274,425 -2,037,493,174,816 -25,362 -18,933
Free Cash Flow -13,693 -9,143